Skip to content
10-Q

Quarterly Report

Intercept Pharmaceuticals, Inc.

0001558370-23-017790

← back to feed
Filed
Nov 6, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Nov 2, 2023 41.83M sh
Shares Diluted Q3 2023 · Sep 30, 2023 41.79M sh
Shares Diluted Q3 2023 · Sep 30, 2023 41.73M sh
Shares Diluted Q3 2023 · Sep 30, 2022 34.29M sh
Shares Diluted Q3 2023 · Sep 30, 2022 31.26M sh
Capex Q3 2023 · Sep 30, 2023 $111K
Capex Q3 2023 · Sep 30, 2022 $865K
Operating Cash Flow Q3 2023 · Sep 30, 2023 −$58.21M
Operating Cash Flow Q3 2023 · Sep 30, 2022 −$21.97M
Long Term Debt Q3 2023 · Sep 30, 2023 $223.86M
Long Term Debt Q3 2023 · Dec 31, 2022 $223.1M
Cash And Equivalents Q3 2023 · Sep 30, 2023 $102.74M
Cash And Equivalents Q3 2023 · Dec 31, 2022 $50.52M
Cash And Equivalents Q3 2023 · Sep 30, 2022 $113.2M
Stockholders Equity Q3 2023 · Sep 30, 2023 $71.85M
Stockholders Equity Q3 2023 · Jun 30, 2023 $67.55M
Stockholders Equity Q3 2023 · Dec 31, 2022 $93.08M
Stockholders Equity Q3 2023 · Sep 30, 2022 $107.68M
Stockholders Equity Q3 2023 · Jun 30, 2022 −$369.83M
Stockholders Equity Q3 2023 · Dec 31, 2021 −$183.96M
Current Liabilities Q3 2023 · Sep 30, 2023 $90.85M
Current Liabilities Q3 2023 · Dec 31, 2022 $230.08M
Total Liabilities Q3 2023 · Sep 30, 2023 $321.32M
Total Liabilities Q3 2023 · Dec 31, 2022 $460.63M
Current Assets Q3 2023 · Sep 30, 2023 $383.45M
Current Assets Q3 2023 · Dec 31, 2022 $540.13M
Total Assets Q3 2023 · Sep 30, 2023 $393.16M
Total Assets Q3 2023 · Dec 31, 2022 $553.71M
Eps Diluted Q3 2023 · Sep 30, 2023 −$0.07
Eps Diluted Q3 2023 · Sep 30, 2023 −$0.98
Eps Diluted Q3 2023 · Sep 30, 2022 $7.80
Eps Diluted Q3 2023 · Sep 30, 2022 $7.76
Eps Basic Q3 2023 · Sep 30, 2023 −$0.07
Eps Basic Q3 2023 · Sep 30, 2023 −$0.98
Eps Basic Q3 2023 · Sep 30, 2022 $7.80
Eps Basic Q3 2023 · Sep 30, 2022 $7.76
Sga Expense Q3 2023 · Sep 30, 2023 $45.44M
Sga Expense Q3 2023 · Sep 30, 2023 $156.44M
Sga Expense Q3 2023 · Sep 30, 2022 $43.27M
Sga Expense Q3 2023 · Sep 30, 2022 $121.01M
Rd Expense Q3 2023 · Sep 30, 2023 $41.51M
Rd Expense Q3 2023 · Sep 30, 2023 $120.53M
Rd Expense Q3 2023 · Sep 30, 2022 $44.03M
Rd Expense Q3 2023 · Sep 30, 2022 $136.75M
Net Income Q3 2023 · Sep 30, 2023 −$2.79M
Net Income Q3 2023 · Sep 30, 2023 −$40.79M
Net Income Q3 2023 · Sep 30, 2022 $267.45M
Net Income Q3 2023 · Sep 30, 2022 $242.64M
Operating Income Q3 2023 · Sep 30, 2023 −$4.62M
Operating Income Q3 2023 · Sep 30, 2023 −$43.37M
Operating Income Q3 2023 · Sep 30, 2022 −$10.14M
Operating Income Q3 2023 · Sep 30, 2022 −$50.23M
Cost Of Revenue Q3 2023 · Sep 30, 2023 $197K
Cost Of Revenue Q3 2023 · Sep 30, 2023 $604K
Cost Of Revenue Q3 2023 · Sep 30, 2022 $424K
Cost Of Revenue Q3 2023 · Sep 30, 2022 $956K
Revenue Q3 2023 · Sep 30, 2023 $88.79M
Revenue Q3 2023 · Sep 30, 2023 $240.47M
Revenue Q3 2023 · Sep 30, 2022 $77.59M
Revenue Q3 2023 · Sep 30, 2022 $208.49M
Short Term Debt Q3 2023 · Dec 31, 2022 $109.57M